Genetic Risk Assessment and BRCA Mutation Testing
Authors: Kelly E. Ormond, Cecelia Bellcross, Scott Weissman
Journal: Annals of Internal Medicine (2006)

Letters21 February 2006Genetic Risk Assessment and BRCA Mutation TestingKelly E. Ormond, MS, Cecelia Bellcross, MS, and Scott Weissman, MSKelly E. Ormond, MSFrom Northwestern University, Chicago, IL 60611; Dean Health Systems–St. Mary's Hospital Medical Center, Madison, WI 53715; and Evanston Northwestern Healthcare, Evanston, IL 60201.Search for more papers by this author, Cecelia Bellcross, MSFrom Northwestern University, Chicago, IL 60611; Dean Health Systems–St. Mary's Hospital Medical Center, Madison, WI 53715; and Evanston Northwestern Healthcare, Evanston, IL 60201.Search for more papers by this author, and Scott Weissman, MSFrom Northwestern University, Chicago, IL 60611; Dean Health Systems–St. Mary's Hospital Medical Center, Madison, WI 53715; and Evanston Northwestern Healthcare, Evanston, IL 60201.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-144-4-200602210-00017 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:The National Society of Genetic Counselors (NSGC) Familial Cancer Risk Counseling Special Interest Group has reviewed the U.S. Preventive Services Task Force (USPSTF) recommendations (1) regarding BRCA genetic risk assessment and commends Annals for creating a patient summary on this topic (2). The NSGC would like to emphasize that the Task Force's recommendations highlight the importance of genetic counseling to the risk assessment process and that genetic counseling facilitates informed decision making about genetic testing and management. In and of itself, counseling has not been associated with increased anxiety or other adverse outcomes. Professionals who are trained ...References1. U.S. Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med. 2005;143:355-61. [PMID: 16144894] LinkGoogle Scholar2. Summaries for patients. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: U.S. Preventive Services Task Force recommendations. Ann Intern Med. 2005;143:I47. [PMID: 16144889] LinkGoogle Scholar Author, Article, and Disclosure InformationAuthors: Kelly E. Ormond, MS; Cecelia Bellcross, MS; Scott Weissman, MSAffiliations: From Northwestern University, Chicago, IL 60611; Dean Health Systems–St. Mary's Hospital Medical Center, Madison, WI 53715; and Evanston Northwestern Healthcare, Evanston, IL 60201.Disclosures: None disclosed. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoGenetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Recommendation StatementU.S. Preventive Services Task Force*Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: U.S. Preventive Services Task Force RecommendationsGenetic Risk Assessment and BRCA Mutation TestingThe Editors Metrics 21 February 2006Volume 144, Issue 4Page: 303-304KeywordsAnxietyCancer geneticsGenetic counselingGenetic diseasesGenetic testingGeneticsMedical geneticsOvarian cancerPopulation genetics ePublished: 21 February 2006 Issue Published: 21 February 2006 Copyright & PermissionsCopyright © 2006 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...